Home / Curated GI articles July 8th, 2021: Penfund announces $85 million investment in Gastro Health
(Webinar) Scope Forward: The Future of GI is Now in Your Hands (Sonic Incytes)
Join Praveen and gastroenterologist Dr. Bradley Sklar to discover insights and practical advice for the industry to thrive, not just survive in the coming decade.
Gastro Health Expands Presence in Ohio (Gastro Health)
Gasto Health has partnered with a group of 17 hospital-based gastroenterologists who will now become part of Gastro Health – Ohio, also known as Ohio GI.
South Suburban Gastroenterology Joins GI Alliance (PR Newswire)
GI Alliance expands in Illinois and the Greater Chicago Area through a partnership with South Suburban Gastroenterology. GI Alliance now represents over 1,000 providers across ten states.
Penfund Announces US$85 million Investment in Gastro Health (GlobeNewswire)
An independent provider of junior capital to North American middle market companies, announced the completion of a second lien debt and equity co-investment in Gastro Health, LLC.
FOMAT Medical Research Partners With Santa Maria Gastroenterology Medical Group (KPVI)
The partnership broadens the reach of medical research across Central California, making hard-to-reach clinical trials readily available for hundreds of thousands of patients.
Lessons Learned on Gastroenterology Future During COVID-19 Pandemic (HCPLive)
A team, led by Fernando Magro, University of Porto, evaluated how the COVID-19 pandemic impacted the quality of health care services for gastroenterology patients.
15 insights on GI net worth, debt & compensation (Becker’s GI & Endoscopy)
Fifty percent of gastroenterologists who took financial hits because of the pandemic expect their income to return to normal in this year.
Twitter Found to Be Key GI Educational Tool (Gastroenterology & Endoscopy News)
Twitter is fast becoming a central way of imparting knowledge in gastroenterology for students and veteran practitioners alike, according to findings from a survey.
Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in COVID-19 (PubMed)
A study indicated hepatic steatosis (HS) was associated with increased disease severity and transaminitis in COVID-19. HS may be relevant in predicting risk of complications related to COVID-19.
Chemotherapy destabilizes gut microbiome in cancer patients (News-Medical.Net)
New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.
Clostridioides difficile: 2 Sets of Guidelines Disagree (Medscape)
With two sets of recommendations being published within a month of each other, clinicians may find themselves trying to reconcile some of the conflicts between the two guidelines.
Endoscopic sleeve gastroplasty may be safe for managing weight loss in NASH (Healio)
Endoscopic sleeve gastroplasty in patients with nonalcoholic steatohepatitis vs. life-style intervention alone was safe and effective for achieving weight loss correlated with significant improvements.
Minnesota GI company building ASC (Becker’s GI & Endoscopy)
MNGI Digestive Health is building a new clinic and ASC in Vadnais Heights, Minnesota. The project is slated to open in April 2022.
Q&A: LinZess reduces bloating, pain in patients with IBS-C (Healio)
Compared with placebo, LinZess significantly decreased abdominal symptoms such as bloating, discomfort and pain in patients with IBS-C, according to results published in the AJG.
One GI Symptom Stuck Around Months After Severe COVID (MedPage Today)
While most GI symptoms resolved for patients hospitalized with COVID-19, inability to gain weight persisted for months, researchers found in a retrospective study.
Probiotic ‘yeast robots’ may one day treat IBD (Medical News Today)
Researchers have developed a multifunctional “designer” probiotic to treat various facets of IBD. It reduces inflammation, reverses tissue damage, and restores the gut microbiome in a mouse model.
Olympus Supports New Recommendation to Begin Colorectal Cancer Screenings at Age 45
Olympus announced its support of the new recommendation issued by the United States Preventive Services Task Force to begin colorectal cancer screenings for all individuals beginning at age 45.
Antibiotic Linked to Rise in Early-Onset Colon Cancer? (Medscape)
Exposure to antibiotics appears to be associated with the development of colon cancer, particularly in younger people, and could be contributing to the increase in early onset colorectal cancer (CRC).
Single-use endoscopy: 3 leading physicians weigh in (Becker’s Hospital Review)
Traditionally, health systems have invested in reusable endoscopy equipment, but an industrywide transition toward single-use endoscopes is gaining momentum.
New Jersey Center Implements Innovative Program For Pancreatic Cyst Surveillance (Gastroenterology & Endoscopy News)
Saint Barnabas Medical Center, N.J., has pioneered one of the first cloud-based data management platforms in the nation to identify, track and monitor patients with pancreatic cysts.
Colon Cancer Is Rising in Younger Adults. Do Sugary Drinks Play a Role? (The New York Times)
As consumption of sugar-laden drinks rose in the 1980s and ’90s, so did colorectal cancer rates among younger adults, a study in nurses found.
Study links low UVB light exposure with increased CRC risk (Becker’s GI & Endoscopy)
Areas where people have lower ultraviolet B light exposure often report higher colorectal cancer rates, according to a study published July 5 in BMC Public Health.
FIT after negative colonoscopy may reduce the risk of incident CRC: Study (Medical Dialogues)
Subsequent FIT must be scheduled after negative colonoscopy to detect missed neoplasms, thereby reducing the risk of incidence, of CRC finds a recent study.
3 biggest threats to ASCs (Becker’s ASC Review)
The power of hospital consolidation and recruiting staff continue to threaten ASC profitability in 2021. Here are the three biggest external risks to ASCs.
Progress Made in Characterizing The Microbiome of Patients With SIBO (Gastroenterology & Endoscopy News)
A sophisticated characterization of the small-bowel microbiome could aid the search for treatments for small intestinal bacterial overgrowth (SIBO).
COVID-19 Drives Digital Health Transformation, Health IT Innovation (EHR Intelligence)
COVID-19 has advanced the digital health transformation, bringing executives to drive health IT innovation with urgency for business resilience.
More Hot headlines in GI